Skip to main content
Log in

Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma

  • Review Article
  • Published:
European Archives of Oto-Rhino-Laryngology Aims and scope Submit manuscript

Abstract

The knowledge of the biology of head and neck squamous cell carcinoma (HNSCC) has had relatively little impact on the improvement in oncologic outcome up to date. However, the identification of oncogenes and tumor suppressor genes (TSGs) involved in cancer progression contributes to the understanding of the molecular pathways involved in oncogenesis and could contribute to individual risk assessment and provide tools for improvement of treatment and targets for therapy based on the alterations in these pathways. The aim of this article is to review the chromosomal aberrations commonly found in HNSCC, to identify the genes in these chromosomal regions suggested to act as (candidate) oncogenes or TSGs, and to discuss the molecular mechanisms modulating their expression.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Braakhuis BJM, Brakenhoff RH, Leemans CR (2010) Gene expression profiling in head and neck squamous cell carcinoma. Curr Opin Otolaryngol Head Neck Surg 18:67–71

    Article  PubMed  Google Scholar 

  2. Lallemant B, Evrard A, Chambon G, Sabra O, Kacha S, Lallemant JG, Lumbroso S, Brouillet JP (2010) Gene expression profiling in head and neck squamous cell carcinoma: clinical perspectives. Head Neck 32:1712–1719

    Article  PubMed  Google Scholar 

  3. Sur I, Tuupanen S, Whitington T, Aaltonen LA, Taipale J (2013) Lessons from functional analysis of genome-wide association studies. Cancer Res 73:4180–4184

    Article  CAS  PubMed  Google Scholar 

  4. Reis-Filho J (2009) Next-generation sequencing. Breast Cancer Res 11(suppl 3):S12

    Article  PubMed Central  PubMed  Google Scholar 

  5. Hanahan D, Weinberg RA (2011) Hallmarks of cancer: the next generation. Cell 144:646–674

    Article  CAS  PubMed  Google Scholar 

  6. Basil CF, Zhao Y, Zavaglia K, Jin P, Panelli MC, Voiculescu S, Mandruzzato S, Lee HM, Seliger B, Freedman RS, Taylor PR, Hu N, Zanovello P, Marincola FM, Wang E (2006) Common cancer biomarkers. Cancer Res 66:2953–2961

    Article  CAS  PubMed  Google Scholar 

  7. Leemans CR, Braakhuis BJM, Brakenhoff RH (2011) The molecular biology of head and neck cancer. Nat Rev Cancer 11:9–22

    Article  CAS  PubMed  Google Scholar 

  8. El-Naggar AK, Mao L, Staerkel G, Coombes MM, Tucker SL, Luna MA, Clayman GL, Lippman S, Goepfert H (2001) Genetic heterogeneity in saliva from patients with oral squamous carcinomas: implications in molecular diagnosis and screening. J Mol Diagn 3:164–170

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  9. Huang Q, Yu GP, McCormick SA, Mo J, Datta B, Mahimkar M, Lazarus P, Schäffer AA, Desper R, Schantz SP (2002) Genomic differences detected by comparative genetic hybridization in head and neck squamous cell carcinoma from different tumor sites. Constructions of oncogenetic trees for tumor progression. Gene Chromosomes Cancer 34:224–233

    Article  CAS  Google Scholar 

  10. Shiomi H, Sugihara H, Kamitani S, Tokugawa T, Tsubosa Y, Okada K, Tamura H, Tani T, Kodama M, Hattori T (2003) Cytogenetic heterogeneity and progression of esophageal squamous cell carcinoma. Cancer Genet Cytogenet 147:50–61

    Article  CAS  PubMed  Google Scholar 

  11. Hunt JL, Barnes L, Lewis JS Jr, Mahfouz ME, Slootweg PJ, Thompson LDR, Cardesa A, Devaney KO, Gnepp DR, Westra WH, Rodrigo JP, Woolgar JA, Rinaldo A, Triantafyllou A, Takes RP, Ferlito A (2014) Molecular diagnostic alterations in squamous cell carcinoma of the head and neck and potential diagnostic applications. Eur Arch Otorhinolaryngol 271:211–223

    Article  PubMed  Google Scholar 

  12. Jones AS (2000) Tumor suppressor genes and head and neck cancer. In: Kitamura K, Steel KP (eds) Genetics in Otolaryngology, vol 56. Karger, Basel, pp 249–260

    Chapter  Google Scholar 

  13. Payne SR, Kemp CJ (2005) Tumor suppressor genetics. Carcinogenesis 26:2031–2045

    Article  CAS  PubMed  Google Scholar 

  14. Rodrigo JP, García-Pedrero JM, Suárez C, Takes RP, Thompson LDR, Slootweg PJ, Woolgar JA, Westra WH, Brakenhoff RD, Rinaldo A, Devaney KO, Williams MD, Gnepp DR, Ferlito A (2012) Biomarkers predicting malignant progression of laryngeal epithelial precursor lesions: a systematic review. Eur Arch Otorhinolaryngol 269:1073–1083

    Article  PubMed  Google Scholar 

  15. Patel KN (2013) Genetic mutations, molecular markers and future directions in research. Oral Oncol 49:711–721

    Article  CAS  PubMed  Google Scholar 

  16. Takebayashi S, Ogawa T, Jung KY, Muallem A, Mineta H, Fisher SG, Grenman R, Carey TE (2000) Identification of a new minimally lost regions on 18q in head and neck squamous cell carcinoma. Cancer Res 60:3397–3403

    CAS  PubMed  Google Scholar 

  17. Kujawski M, Sarlomo-Rikala M, Gabriel A, Szyfter K, Knuutila S (1999) Recurrent DNA copy number losses associated with metastasis of larynx carcinoma. Genes Chromosomes Cancer 26:253–257

    Article  CAS  PubMed  Google Scholar 

  18. Singh B, Gogineni SK, Sacks PG, Shaha AR, Shah JP, Stoffel A, Rao PH (2001) Molecular cytogenetics characterization of head and neck squamous cell carcinoma and refinement of 3q amplification. Cancer Res 61:4506–4513

    CAS  PubMed  Google Scholar 

  19. Speicher MR, Howe C, Crotty P, du Manoir S, Costa J, Ward DC (1995) Comparative genomic hybridization detects novel deletions and amplifications in head and neck squamous cell carcinoma. Cancer Res 55:1010–1013

    CAS  PubMed  Google Scholar 

  20. Järvinen AK, Autio R, Haapa-Paananen S, Wolf M, Saarela M, Grénman R, Leivo I, Kallioniemi O, Mäkitie AA, Monni O (2006) Identification of target genes in laryngeal squamous cell carcinoma by high-resolution copy number and gene expression microarray analyses. Oncogene 25:6997–7008

    Article  PubMed  Google Scholar 

  21. Hashimito Y, Oga A, Kawauchi S, Furuya T, Shimizu N, Nakano T, Imate Y, Yamashita H, Sasaki K (2001) Amplification of 3q26-qter correlates with tumor progression in head and neck squamous cell carcinomas. Cancer Genet Cytogenet 129:52–56

    Article  Google Scholar 

  22. Riazimand SH, Welkoborsky HJ, Bernauer HS, Jacob R, Mann WJ (2002) Investigation for fine mapping of amplifications in chromosome 3q26.3-28 frequently occurring in squamous cell carcinomas of the head and neck. Oncology 63:385–392

    Article  CAS  PubMed  Google Scholar 

  23. Brieger J, Kastner J, Gosepath J, Mann WJ (2006) Evaluation of microsatellite amplification at chromosomal locus 3q26 as a surrogate marker for premalignant change in mucosa surrounding head and neck squamous cell carcinoma. Cancer Genet Cytogenet 167:26–31

    Article  CAS  PubMed  Google Scholar 

  24. Redon R, Muller D, Caulee K, Wanherdrick K, Abecassis J, du Manoir S (2001) A simple specific pattern of chromosomal aberration at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains. Cancer Res 61:4122–4129

    CAS  PubMed  Google Scholar 

  25. Pedrero JMG, Carracedo DG, Pinto CM, Zapatero AH, Rodrigo JP, Nieto CS, Gonzalez MV (2005) Frequent genetic and biochemical alterations of the PI 3-K/AKT/PTEN pathway in head and neck carcinoma. Int J Cancer 114:242–248

    Article  CAS  PubMed  Google Scholar 

  26. Murugan AK, Munirajan AK, Tsuchida N (2013) Genetic deregulation of the PIK3CA oncogene in oral cancer. Cancer Lett 338:193–203

    Article  CAS  PubMed  Google Scholar 

  27. Sarkaria I, O-charoenrat P, Talbot SG, Reddy PG, Ngai I, Maghami E, Patel KN, Lee B, Yonekawa Y, Dudas M, Kaufman A, Ryan R, Ghossein R, Rao PH, Stoffel A, Ramanathan Y, Singh B (2006) Squamous cell carcinoma related oncogene/DCUN1D1 is highly conserved and activated by amplification in squamous cell carcinomas. Cancer Res 66:9437–9444

    Article  CAS  PubMed  Google Scholar 

  28. Virgilio L, Shuster M, Gollin SM, Veronese ML, Ohta M, Huebner K, Croce CM (1996) FHIT gene alterations in head and neck squamous cell carcinomas. Proc Nat Acad Sci USA 93:9770–9775

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  29. Iliopoulos D, Guler G, Han SY, Druck T, Ottey M, McCorkell KA, Huebner K (2006) Roles of FHIT and WWOX fragile genes in cancer. Cancer Lett 232:27–36

    Article  CAS  PubMed  Google Scholar 

  30. Sasiadek MM, Stembalska-Kozlowska A, Smigiel R, Ramsey D, Kayademir T, Blin N (2004) Impairment of MLH1 and CDKN2A in oncogenesis of laryngeal cancer. Br J Cancer 90:1594–1599

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  31. Sengupta S, Chakrabarti S, Roy A, Panda CK, Roychoudhury S (2007) Inactivation of human MutL homolog1 and MutS homolog 2 genes in head and neck squamous cell carcinoma tumors and leukoplakia samples by promoter hypermethylation and its relations with microsatellite instability phenotype. Cancer 109:703–712

    Article  CAS  PubMed  Google Scholar 

  32. Wang J, Chen H, Fu S, Xu ZM, Sun KL, Fu WN (2011) The involvement of CHD5 hypermethylation in laryngeal squamous cell carcinomas. Oral Oncol 47:601–608

    Article  PubMed  Google Scholar 

  33. da Silva Veiga LC, Bérgamo NA, dos Reis PP, Kowalski LP, Rogatto SR (2003) DNA gains at 8q23.2: a potential early marker in head and neck carcinomas. Cancer Genet Cytogenet 146:110–115

    Article  PubMed  Google Scholar 

  34. Giefing M, Zemke N, Brauze D, Kostrzewska-Poczekaj M, Luczak M, Szaumkessel M, Pelinska K, Kiwerska K, Tönnies H, Grenman R, Figlerowicz M, Siebert R, Szyfter K, Jarmuz M (2011) High resolution array CGH and expression profiling identifies PTPRD and PCDH17/PCH68 as tumor suppressor gene candidates in laryngeal squamous cell carcinoma. Genes Chromosomes Cancer 50:154–166

    Article  CAS  PubMed  Google Scholar 

  35. Poetsch M, Lorenz G, Kleist B (2002) Detection of new PTEN/MMAC1 mutations in head and neck squamous cell carcinomas with loss of chromosome 10. Cancer Genet Cytogenet 132:20–24

    Article  CAS  PubMed  Google Scholar 

  36. Squarize CH, Castilho RM, Abrahao AC, Molinolo A, Lingen MW, Gutkind JS (2013) PTEN deficiency contributes to the development and progression of head and neck cancer. Neoplasia 15:461–471

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  37. Mriouah J, Boura C, Gargouri M, Plénat F, Faivre B (2014) PTEN expression is involved in the invasive properties of HNSCC: a key protein to consider in locoregional recurrence. Int J Oncol 44:709–716

    CAS  PubMed  Google Scholar 

  38. Rodríguez MJ, Acha A, Ruesga MT, Rodríguez C, Rivera JM, Aguirre JM (2007) loss of expression of DNA repair enzyme MGMT in oral leukoplakia and early oral squamous cell carcinoma. A prognostic tool? Cancer Lett 245:263–268

    Article  PubMed  Google Scholar 

  39. Esteller M, Toyota M, Sanchez-Cespedes M, Capella G, Peinado MA, Watkins DN, Issa JP, Sidransky D, Baylin SB, Herman JG (2000) Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 60:2368–2371

    CAS  PubMed  Google Scholar 

  40. Jarmuz-Szymczak M, Pelinska K, Kostrzewska-Poczekaj M, Bembnista E, Giefing M, Brauze D, Szaumkessel M, Marszalek A, Janiszewska A, Kiwerska K, Bartochowska A, Grenman R, Szyfter W, Szyfter K (2013) Heterogeneity of 11q13 region rearrangement in laryngeal squamous cell carcinoma analyzed by microarray platforms and fluorescence in situ hybridization. Mol Biol Rep 40:4161–4171

    Article  CAS  PubMed  Google Scholar 

  41. Jarmuż M, Grenman R, Golusinski W, Szyfter K (2005) Aberrations of 11q13 in laryngeal squamous cell lines and their prognostic significance. Cancer Genet Cytogenet 160:82–88

    Article  PubMed  Google Scholar 

  42. Mishra R (2013) Cell cycle-regulatory cyclins and their deregulation in oral cancer. Oral Oncol 49:475–481

    Article  CAS  PubMed  Google Scholar 

  43. Rodrigo JP, Garcia LA, Ramos S, Lazo PS, Suárez C (2000) EMS1 gene amplification correlates with poor prognosis in squamous cell carcinomas of the head and neck. Clin Cancer Res 6:3177–3182

    CAS  PubMed  Google Scholar 

  44. Huang X, Gollin SM, Raja S, Godfrey TE (2002) High-resolution mapping of the 11q13 amplicon and identification of a gene, TAOS1, that is amplified and overexpressed in oral cancer cells. Proc Nat Acad Sci USA 99:11369–11374

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  45. Ayoub C, Wasylyk C, Li Y, Thomas E, Marisa L, Robé A, Roux M, Abecassis J, de Reyniès A, Wasylyk B (2010) ANO1 amplification and expression in HNSCC with a high propensity for future distant metastasis and its functions in HNSCC cell lines. Br J Cancer 103:715–726

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  46. Pattje WJ, Melchers LJ, Slagter-Menkema L, Mastik MF, Schrijvers ML, Gibcus JH, Kluin PM, Hoegen-Chouvalova O, van der Laan BF, Roodenburg JL, van der Wal JE, Schuuring E, Langendijk JA (2013) FADD expression is associated with regional and distant metastasis in squamous cell carcinoma of the head and neck. Histopathology 63:263–270

    Article  CAS  PubMed  Google Scholar 

  47. Wilkerson PM, Reis-Filho JS (2013) The 11q13-q14 amplicon: clinicopathological correlation and potential drivers. Genes Chromosomes Cancer 52:333–355

    Article  CAS  PubMed  Google Scholar 

  48. Stembalska A, Blin N, Ramsey D, Sasiadek MM (2006) Three distinct regions of deletion on 13q in squamous cell carcinoma of the larynx. Oncol Rep 16:417–421

    CAS  PubMed  Google Scholar 

  49. Gunduz M, Ouchida M, Fukushima K, Hanafusa H, Etani T, Nishioka S, Nishizaki K, Shimizu K (2000) Genomic structure of the human ING1 gene and tumor-specific mutations detected in head and neck squamous cell carcinoma. Cancer Res 60:3143–3146

    CAS  PubMed  Google Scholar 

  50. Sivadas VP, George NA, Kattoor J, Kannan S (2013) Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis. Genes Chromosomes Cancer 52:1042–1052

    Article  CAS  PubMed  Google Scholar 

  51. Gomes MG, Diniz GG, Oliveira CS, Tavassoli M, Odell EW, Gomez RS, De Marco L (2011) Impact of WWOX alterations on p73, ΔNp73, p53, cell proliferation and DNA ploidy in salivary gland neoplasms. Oral Dis 17:564–571

    Article  CAS  PubMed  Google Scholar 

  52. Rothenberg SM, Ellisen LW (2012) The molecular pathogenesis of head and neck squamous cell carcinoma. J Clin Invest 122:1951–1957

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  53. Tandon S, Tudur-Smith C, Riley RD, Boyd MT, Jones TM (2010) A systematic review of p53 as a prognostic factor of survival in squamous cell carcinoma of the four main anatomical subsites of the head and neck. Cancer Epidemiol Biomarkers Prev 19:574–587

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  54. Tassone P, Old M, Teknos TN, Pan Q (2013) p53-based therapeutics for head and neck squamous cell carcinoma. Oral Oncol 49:733–737

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  55. Li Y, Chen Z (2004) Molecular cloning and characterization of LCRG1, a novel gene localized to the tumor suppressor locus D17S800-D17S930. Cancer Lett 209:75–85

    Article  CAS  PubMed  Google Scholar 

  56. Zhang X, Xiao Z, Chen Z, Li C, Li J, Yanhui Y, Yang F, Oyang Y, Yang YX (2006) Comparative proteomics analysis of the proteins associated with laryngeal carcinoma-related gene 1. Laryngoscope 116:224–230

    Article  CAS  PubMed  Google Scholar 

  57. Qiu W, Schönleben F, Thaker HM, Goggins M, Su GH (2006) A novel mutation of STK11/LKB1 gene leads to the loss of cell growth in head and neck squamous cell carcinoma. Oncogene 25:2937–2942

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  58. Ohta M, Mimori K, Fukuyoshi Y, Kita Y, Motoyama K, Yamashita K, Ishii H, Inoue H, Mori M (2008) Clinical significance of the reduced expression of G protein gamma 7 (GNG7) in oesophageal cancer. Br J Cancer 98:410–417

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  59. Hartmann S, Szaumkessel M, Salaverria I, Simon R, Sauter G, Kiwerska K, Gawecki W, Bodnar M, Marszalek A, Richter J, Brauze D, Zemke N, Jarmuz M, Hansmann ML, Siebert R, Szyfter K, Giefing M (2012) Loss of protein expression and recurrent DNA hypermethylation of the GNG7 gene in squamous cell carcinoma of the head and neck. J Appl Genet 53:167–174

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  60. Wu X, Cao W, Wang X, Zhang J, Qin X, Lv Z, Wu Y, Chen W (2013) TGM3, a candidate tumor suppressor gene, contributes to human head and neck cancer. Mol Cancer 12:151

    Article  PubMed Central  PubMed  Google Scholar 

  61. Kostrzewska-Poczekaj M, Gieging M, Jarmuz M, Brauze D, Pelinska K, Grenman R, Bartochowska A, Szyfter W, Szyfter K (2010-2011) Recurrent amplification in the 22q11 region in laryngeal squamous cell carcinoma results in overexpression of the CRKL but not the MAPK1 oncogene. Cancer Biomark 8:11–19

    CAS  PubMed  Google Scholar 

  62. Rettori MM, de Carvalho AC, Bomfim Longo AL, de Oliveira CZ, Kowalski LP, Carvalho AP, Vettore AL (2013) Prognostic significance of TIMP3 hypermethylation in post-treatment salivary rinse from head and neck squamous cell carcinoma patients. Carcinogenesis 34:20–27

    Article  CAS  PubMed  Google Scholar 

  63. Worsham MJ, Chen KM, Meduri V, Nygren AOH, Errami A, Schouten JP, Benninger MS (2006) Epigenetic events of disease progression in head and neck squamous cell carcinoma. Acta Otolaryngol Head Neck Surg 132:668–677

    Article  Google Scholar 

  64. Baba S, Yamada Y, Hatano Y, Miyazaki Y, Mori H, Shibata T, Hara A (2009) Global DNA hypomethylation suppresses squamous carcinogenesis in the tongue and esophagus. Cancer Sci 100:1186–1191

    Article  CAS  PubMed  Google Scholar 

  65. Paluszczak J, Misiak P, Wierzbicka M, Woźniak A, Baer-Dubowska W (2011) Frequent hypermethylation of DAPK, RARbeta, MGMT, RASSF1A and FHIT in laryngeal squamous cell carcinomas and adjacent normal mucosa. Oral Oncol 47:104–107

    Article  CAS  PubMed  Google Scholar 

  66. Dikshit RP, Gillio-Tos A, Brennan P, De Marco L, Fiano V, Martinez-Peñuela JM, Boffetta P, Merletti F (2007) Hypermethylation, risk factors, clinical characteristics, and survival in 235 patients with laryngeal and hypopharyngeal cancers. Cancer 110:1745–1751

    Article  CAS  PubMed  Google Scholar 

  67. Wang F, Song G, Liu M, Li X, Tang H (2011) miRNA-1 targets fibronectin1 and suppresses the migration and invasion of the HEp2 laryngeal squamous carcinoma cell line. FEBS Lett 585:3263–3269

    Article  CAS  PubMed  Google Scholar 

  68. Hendrix A, Westbroek W, Bracke M, De Wever O (2010) An Ex(o)citing machinery for invasive tumor growth. Cancer Res 70:9533–9537

    Article  CAS  PubMed  Google Scholar 

  69. Luo X, Fan S, Huang W, Zhai S, Ma Z, Li P, Sun SY, Wang X (2012) Downregulation of IRS-1 promotes metastasis of head and neck squamous cell carcinoma. Oncol Rep 28:659–667

    CAS  PubMed  Google Scholar 

  70. Yan J, Huang Q (2012) Genomics screens for metastasis genes. Cancer Metastasis Rev 31:419–428

    Article  PubMed Central  CAS  PubMed  Google Scholar 

  71. Schaaij-Visser TBM, Graveland AP, Gauci S, Braakhuis BJM, Buijze M, Heck AJR, Kuik DJ, Bloemena E, Leemans CR, Slijper M, Brakenhoff RH (2009) Differential proteomic identifies protein biomarkers that predict local relapse of head and neck squamous cell carcinomas. Clin Cancer Res 15:7666–7675

    Article  CAS  PubMed  Google Scholar 

  72. Gutiérrez VF, Marcos CÁ, Llorente JL, Guervós MA, Iglesias FD, Tamargo LA, Hermsen M (2012) Genetic profile of second primary tumors and recurrences in head and neck squamous cell carcinomas. Head Neck 34:830–839

    Article  PubMed  Google Scholar 

  73. Glazer CA, Chang SS, Ha PK, Califano JA (2009) Applying the molecular biology and epigenetics of head and neck cancer in everyday clinical practice. Oral Oncol 45:440–446

    Article  CAS  PubMed  Google Scholar 

  74. Knudsen ES, Wang JY (2010) Targeting the RB-pathway in cancer therapy. Clin Cancer Res 16:1094–1099

    Article  PubMed Central  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alfio Ferlito.

Additional information

This paper was written by members of the International Head and Neck Scientific Group (http://www.IHNSG.com).

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Szyfter, K., Wierzbicka, M., Hunt, J.L. et al. Frequent chromosomal aberrations and candidate genes in head and neck squamous cell carcinoma. Eur Arch Otorhinolaryngol 273, 537–545 (2016). https://doi.org/10.1007/s00405-014-3339-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00405-014-3339-1

Keywords

Navigation